FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

FONAR CorporationNASDAQ: FONR

Common Stock · Q3 FY2026 · quarter ended Mar 2026

Common stock broadly unchanged from a year ago

Common stock stood at $1K at the end of Q3 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at -1.7% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
  • Common stock increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1K+0.0% QoQ
Last fiscal yearJun 2025
$660-1.9% YoY
Year agoMar 2025
$1K+0.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year-1.9%——
3-year CAGR-1.7%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
660 USD
Year-over-year change
-1.9%
4-year CAGR
-1.3%

Common Stock vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +0.0% is the 6th highest of 8, against a peer median of +10.5%.
  • Common stock amounts to 0.0% of total assets for FONR, versus a peer median of 0.1%.
FONR Competitors
Common Stock for FONR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IFRXInflaRx N.V.Mar 2026€8.68M EUR+6.8%+17.4%17.7%
LUNGPulmonx CorporationMar 2026$319K USD+697.5%+3.4%0.3%
APYXApyx Medical CorporationMar 2026$42K USD+10.5%+6.3%0.1%
HYPRHyperfine, Inc.Mar 2026$10K USD+25.0%+12.6%0.0%
VANIVivani Medical, Inc.Mar 2026$8K USD+33.3%+17.0%0.0%
ARTVArtiva Biotherapeutics, Inc.Mar 2026$3K USD+0.0%—0.0%
FONRFONAR CorporationMar 2026$1K USD+0.0%-1.7%0.0%
RCELAVITA Medical, Inc.Mar 2026-$632K USD-21166.7%—1.2%
Peer median (excluding FONR) —+10.5%+12.6%0.1%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents44.46M48.72M51.28M56.34M56.33M
Short-term Investments32.18K32.33K32.8K136.1K120.49K
Net Receivables61.2M66.47M70.17M79.85M82.94M
Inventory1.66M2.36M2.57M2.72M2.81M
Other Current Assets0001.29M2.46M
Total Current Assets108.58M118.69M125.66M140.32M144.67M
Property, Plant & Equipment (Net)53.11M57.44M55.94M57.67M54.04M
Goodwill4.27M4.27M4.27M4.27M4.27M
Intangible Assets4.04M3.7M3.43M2.87M2.99M
Long-term Investments01.87M710.09K00
Tax Assets15.96M12.84M10.04M7.22M6.35M
Other Non-current Assets3.55M526.27K523.51K1.89M4.58M
Total Non-current Assets80.92M80.66M74.92M73.92M72.24M
Total Assets189.51M199.34M200.58M214.25M216.91M
Account Payables1.87M1.55M1.58M1.86M1.3M
Short-term Debt173.21K40.08K43.77K47K0
Tax Payables1.42M630.7K241.39K1.66M640.32K
Deferred Revenue5.11M4.65M4.43M4.31M5.22M
Other Current Liabilities943.24K1.07M785.75K1.6M1.89M
Total Current Liabilities20.05M16.75M15.62M17.86M17.12M
Long-term Debt760.25K155.38K115.08K66.94K0
Deferred Tax Liabilities238.32K215.73K394.76K371.56K321.16K
Deferred Revenue (Non-current)2.8M1.86M760.24K1.17M3.8M
Other Non-current Liabilities263.99K199.2K134.41K124.69K265.52K
Total Non-current Liabilities34.09M36.36M34.13M39.6M39.68M
Total Liabilities54.14M53.11M49.75M57.46M56.8M
Common Stock695695685673660
Retained Earnings(46.01M)(33.57M)(24.19M)(13.62M)(5.29M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest(3.05M)(4.05M)(7.08M)(9.18M)(12.5M)
Total Equity135.37M146.24M150.83M156.79M160.1M
Total Debt34.69M38.22M37.01M41.68M38.92M
Net Debt(9.77M)(10.51M)(14.27M)(14.67M)(17.42M)

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.